MYC and hepatoblastoma: We explored potential downstream signaling pathways known to be involved in hepatoblastoma [14–16] and noted that Akt and Erk were dephosphorylated and c-myc expression was decreased with FTY720 treatment; findings similar to what other investigators have demonstrated with PP2A activation [9–11].